356 related articles for article (PubMed ID: 26617684)
1. Immune-phenotypical markers for the differential diagnosis of melanocytic lesions.
Botti G; Marra L; Anniciello A; Scognamiglio G; Gigantino V; Cantile M
Int J Clin Exp Pathol; 2015; 8(9):9742-51. PubMed ID: 26617684
[TBL] [Abstract][Full Text] [Related]
2. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
[TBL] [Abstract][Full Text] [Related]
3. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
4. Atypical Spitz Tumors: A Diagnostic Challenge.
Harms KL; Lowe L; Fullen DR; Harms PW
Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
[TBL] [Abstract][Full Text] [Related]
5. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
[TBL] [Abstract][Full Text] [Related]
6. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
Garola R; Singh V
Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
[TBL] [Abstract][Full Text] [Related]
7. Spitz Nevus and Other Spitzoid Tumors in Children -Part 1: Clinical, Histopathologic, and Immunohistochemical Features.
Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):7-19. PubMed ID: 31787210
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
9. Atypical melanocytic lesions: a historical overview.
Manchi M; Canzonieri V
Pol J Pathol; 2019; 70(1):26-32. PubMed ID: 31556548
[TBL] [Abstract][Full Text] [Related]
10. Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumors.
Zaremba A; Jansen P; Murali R; Mayakonda A; Riedel A; Philip M; Rose C; Schaller J; Müller H; Kutzner H; Möller I; Stadtler N; Kretz J; Sucker A; Bankfalvi A; Livingstone E; Zimmer L; Horn S; Paschen A; Plass C; Schadendorf D; Hadaschik E; Lutsik P; Griewank K
Int J Cancer; 2022 Nov; 151(9):1542-1554. PubMed ID: 35737508
[TBL] [Abstract][Full Text] [Related]
11. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
12. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
13. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
[TBL] [Abstract][Full Text] [Related]
14. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
15. Spitz nevus, Spitz tumor, and spitzoid melanoma: a comprehensive clinicopathologic overview.
Ferrara G; Gianotti R; Cavicchini S; Salviato T; Zalaudek I; Argenziano G
Dermatol Clin; 2013 Oct; 31(4):589-98, viii. PubMed ID: 24075547
[TBL] [Abstract][Full Text] [Related]
16. The utilization of spitz-related nomenclature in the histological interpretation of cutaneous melanocytic lesions by practicing pathologists: results from the M-Path study.
Zhao G; Lee KC; Peacock S; Reisch LM; Knezevich SR; Elder DE; Piepkorn MW; Elmore JG; Barnhill RL
J Cutan Pathol; 2017 Jan; 44(1):5-14. PubMed ID: 27686456
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of neuropilin-2 as a simple and sensitive diagnostic assay for spitzoid melanocytic lesions.
Eisenstein A; Panova IP; Chung HJ; Goldberg LJ; Zhang Q; Lazova R; Bhawan J; Busam KJ; Symanowski JT; Alani RM; Ryu B
Melanoma Res; 2018 Feb; 28(1):71-75. PubMed ID: 29227334
[TBL] [Abstract][Full Text] [Related]
18. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
[TBL] [Abstract][Full Text] [Related]
19. Spitzoid melanoma.
Kamino H
Clin Dermatol; 2009; 27(6):545-55. PubMed ID: 19880042
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?
Busam KJ; Pulitzer M
Adv Anat Pathol; 2008 Sep; 15(5):253-62. PubMed ID: 18724099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
